Cargando…
Patient specific circulating tumor DNA fingerprints to monitor treatment response across multiple tumors
BACKGROUND: Circulating tumor DNA (ctDNA) offers a convenient way to monitor tumor progression and treatment response. Because tumor mutational profiles are highly variable from person to person, a fixed content panel may be insufficient to track treatment response in all patients. METHODS: We desig...
Autores principales: | Li, Jiaping, Jiang, Wei, Wei, Jinwang, Zhang, Jianwei, Cai, Linbo, Luo, Minjie, Wang, Zhan, Sun, Wending, Wang, Shengzhou, Wang, Chen, Dai, Chun, Liu, Jun, Wang, Guan, Wang, Jiping, Xu, Qiang, Deng, Yanhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7395971/ https://www.ncbi.nlm.nih.gov/pubmed/32738923 http://dx.doi.org/10.1186/s12967-020-02449-y |
Ejemplares similares
-
Comprehensive analysis of potential immunotherapy genomic biomarkers in 1000 Chinese patients with cancer
por: Zang, Yuan‐sheng, et al.
Publicado: (2019) -
The Mechanical Fingerprint of Circulating Tumor Cells (CTCs) in Breast Cancer Patients
por: Nel, Ivonne, et al.
Publicado: (2021) -
Detection of circulating tumor cells: opportunities and challenges
por: Ju, Siwei, et al.
Publicado: (2022) -
Landscape of circulating metabolic fingerprinting for keloid
por: Hu, Yu, et al.
Publicado: (2022) -
Circulating tumor cells and circulating tumor DNA in breast cancer diagnosis and monitoring
por: ALEMZADEH, EFFAT, et al.
Publicado: (2023)